Catalyst Wire Dossier Catalyst Wire Dossier

Kunxian

Tripterygium wilfordii glycosides
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Kunxian, covering 2017-03-09 to 2017-03-09. Get the full timeline:

Most recent: Clinical Trial Update: Kunxian for the Treatment of Rheumatoid Arthritis [Phase 4]

See pricing